Synchrony Financial (SYF) is in focus after expanding its CareCredit offering to LiveLoveSpa.com. The move brings flexible financing directly into online cosmetic and wellness checkouts as beauty eCommerce continues to see strong consumer interest.

The CareCredit expansion comes as Synchrony’s 1-year total shareholder return of 25.26% contrasts with a share price that is down 16.39% year to date, suggesting earlier gains are being reassessed even after a recent 6.16% 90 day share price return.

If this kind of consumer finance story has your attention, it may be a good moment to see what else is moving and check out 21 top founder-led companies

With Synchrony trading at a reported 54.60% intrinsic discount and about 26.05% below the average analyst price target, investors now have to ask whether they are seeing genuine value or whether the market already reflects expectations for future growth.

Most Popular Narrative: 32.6% Undervalued

The most followed valuation narrative pins Synchrony Financial’s fair value at $105 per share, versus the last close at $70.78, framing the current discount as sizeable in absolute dollar terms.

In plain valuation terms:

Your DCF/Excess Return analysis suggests Synchrony Financial’s intrinsic value is around $145 per share, meaning the stock could be trading at a steep discount (~40% undervalued) versus its fundamental long-term economic profit potential. Current market pricing and consensus analyst targets are significantly lower, around the mid-$80s to ~$100, mainly because of short-term earnings expectations and risk pricing. The recent Federal Reserve rate cut should support lending economics and may be a positive tailwind for SYF’s profitability, but market sentiment and macro risk continue to temper valuation multiples.

Curious how a fair value well above $100 is built on book value, excess returns and a specific discount rate and growth path. The narrative leans heavily on sustained profitability metrics and the gap between return on equity and the cost of equity. Want to see which long run assumptions have the biggest impact on that valuation gap.

Result: Fair Value of $105 (UNDERVALUED)

However, this hinges on credit costs and regulation. A spike in consumer delinquencies or tighter CFPB rules could both quickly compress that perceived valuation gap.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Next Steps

Given the mix of optimism and caution in this story, it makes sense to review the underlying data yourself and be prepared to act quickly. To balance both sides of the argument, start by weighing the 5 key rewards and 3 important warning signs

Looking for more investment ideas?

If you stop with just one stock, you risk missing opportunities that better fit your goals. Widen your view and scan a few targeted shortlists.

• Target potential value plays by reviewing companies on the 47 high quality undervalued stocks that pair pricing gaps with solid underlying metrics.
• Prioritise resilience by checking out stocks in the 65 resilient stocks with low risk scores that score well on stability and downside protection.
• Spot future contenders early by scanning the screener containing 22 high quality undiscovered gems and seeing which lesser known stocks still show strong fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.